Conférence

Bordeaux Cancer Initiative

Réalisation : 7 novembre 2014 Mise en ligne : 7 novembre 2014
  • document 1 document 2 document 3
  • niveau 1 niveau 2 niveau 3
  • audio 1 audio 2 audio 3
Descriptif

Translational science : how to move from biology to clinical applications

Upon request of the University, the SIRIC was mandated to develop a transversal cancer axis at the University. The axis development was led by BRIO management team along with a committee representing various disciplines within the University having an interest for cancer research. The axis definition focused on cancer research complementary to the SIRIC BRIO and is based mostly on basic and technological research. Five programmes are part of the axis: interaction radiation/living beings, nanotechnologies and innovations, tumor microenvironment, risk and predictions, cell remodelling. 150 scientists from 27 Bordeaux institutes are involved in this project.In addition, BRIO proposes to develop a translational research center at the University. The project would include an optimisation of existing capacities and resources, an improved link with the industry, a dedicated facility built into the “Plan Campus” and a training programme for scientists interested in translational science. The project is also supported by the recently created regenerative medicine institute, which shares the same interests in translational science.

Cette présentation a été donnée dans le cadre du ScientificBRIO Day 2 organisé annuellement par le SIRIC BRIO et qui a pour but de réunirtous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.

Intervenants
Thèmes
Notice
Langue :
Anglais
Crédits
Université de Bordeaux - Service Audiovisuel et Multimédia (Production), Université de Bordeaux - Service Audiovisuel et Multimédia (Publication), Université de Bordeaux - Service Audiovisuel et Multimédia (Réalisation)
Conditions d'utilisation
Creative Commons (BY NC)
Citer cette ressource:
Univ Bordeaux. (2014, 7 novembre). Bordeaux Cancer Initiative. [Vidéo]. Canal-U. https://www.canal-u.tv/75311. (Consultée le 4 juillet 2022)
Contacter

Dans la même collection

  • BRIO support to scientists
    Conférence
    00:13:28
    BRIO support to scientists
    Dessis
    Damien

    BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research

  • Multisarc
    Conférence
    00:13:08
    Multisarc
    Italiano
    Antoine

    Translational science : how to move from biology to clinical applications Soft-tissues sarcomas represent an heterogeneous group of tumors. Stadard of care is surgical resection followed by

  • Curing leukemia ?
    Conférence
    00:19:52
    Curing leukemia ?
    Mahon
    François-Xavier

    Non-pharmaceutical medical innovations and public health The use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid

  • Standardizing G8 evaluation
    Conférence
    00:15:00
    Standardizing G8 evaluation
    Soubeyran
    Pierre

    Non-pharmaceutical innovations and public health Management of the frail elderly with cancer is a challenge. Beside a poor outcome as compared to younger subjects, physicians will face increased

  • Innovation reimbursement
    Conférence
    00:09:10
    Innovation reimbursement
    Fillatreau
    Christian

    Interface technology/clinical/SHS/public health : case study interventional radiology Novel diagnostic and therapeutic strategies is a continuum of 3 strongly associated phases : clinical

  • Technique, research and benefits
    Conférence
    00:22:10
    Technique, research and benefits
    Grenier
    Nicolas
    Palussière
    Jean

    Interface technology/clinical/SHS/public health : case study interventional radiology   >> Jean Palussière Radiology in oncology or so called interventional oncology is now considered by certain

Avec les mêmes intervenants

  • Flash talk - Call for proposal FAC 2014
    Conférence
    01:02:56
    Flash talk - Call for proposal FAC 2014
    Elustondo
    Frédéric
    Wodrich
    Harald
    Faustin
    Benjamin
    Saltel
    Frédéric
    Cognet
    Laurent

    Personalized breast cancer therapy based on viral functional assays to score pathway activity Harald Wodrich, University of Bordeaux State-of-the-art mass sequencing technology has paved the road

  • BRIO support to scientists
    Conférence
    00:13:28
    BRIO support to scientists
    Dessis
    Damien

    BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research

Sur le même thème